what is in glp-1 drugs Drugs: Fighting Diabetes and Weight Gainπ - General Evolution of GLPβ1 Receptor Agonists
Description
PMID: 19931066
However, their use must be balanced against significant considerations including safety concerns, high costs, and the need for comprehensive monitoring and support
PLoS One 13 , e0196625 (2018)
The goal is not to scare patients away from treatment
We must keep these cases in mind as these drugs are adopted widely as treatments for various diseases
Leblanc, Y., Berger, M., Seifert, A., Bihoreau, N
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
